Kiora Pharmaceuticals
As of the edition of 20 October 2026, Kiora Pharmaceuticals runs 3 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
- Eyegate Pharmaceuticals, Inc.: acquired in 2021; successor Kiora Pharmaceuticals, Inc.
Drugs by status
| Status | Count |
|---|---|
| Active | 2 |
| Stopped | 1 |
| Total | 3 |
Where its trials are
- Eye: 4 trials led
- Inherited and neonatal: 2 trials led